Chronic administration of Empagliflozin induces cardioprotection in vivo in absence of diabetes mellitus

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Mechanisms underlying pharmacotherapy Antidiabetic Pharmacotherapy ESC Premium Access ESC Congress 2019

ESC 365 is supported by

ESC 365 is supported by